Misoprostol in Termination of First Trimester Missed Abortion
Misoprostol in Termination of First Trimester Missed Abortion
The purpose of this study is to determine whether oral versus vaginal misoprostol is
 effective in termination of first trimester missed abortion and to compare between two
 different routes.
Objective: To compare the effectiveness of oral versus vaginal misoprostol prior to surgical
 termination of first trimester missed abortion as cervical priming agent , the difference of
 cervical dilatation immediately prior to operation , the duration of operation and side
 effects between two treatment groups.

 Design: This study was conducted as randomised study.

 Setting: Maternity Teaching Hospital in Hawler/ Kurdistan/ Iraq.

 Population: Over a period of six months from the first of January to the thirtieth of June,
 2008, one hundred women were included in this study. They were cases of first trimester
 abortion (6-12 weeks).

 Method: Patients were randomly selected for the type of treatment they received. The first
 group (oral) were assigned to receive 400 micrograms of misoprostol orally as preoperative
 cervical priming agent, where as the second group (vaginal) were allocated to have treatment
 either with vaginal misoprostol to receive 400 micrograms vaginally.

 Main outcome measure: Oral versus vaginal misoprostol as cervical ripening agent prior to
 termination of first trimester missed abortion.

 Keywords: First trimester, missed abortion, misoprostol, cervical ripening, oral, vaginal.
Inclusion Criteria:

 -  All patients were cases of first trimester missed abortion.

 -  They have uneventful history apart from history of slight vaginal bleeding, with
 normal general examination. Gynecological examination revealed no vaginal bleeding or
 discharge with no dilatation of the internal os with enlarged uterus.

 Exclusion Criteria:

 -  Cases with suspected or proven ectopic pregnancy, history of Caesarean section,
 medical diseases, a known hypersensitivity to a drug, smokers, patients with abnormal
 results of investigation and the presence of vaginal bleeding were excluded from the
 study.